RA Capital Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $431M | Hold |
|
|||||
|
2025
Q2 | $389M | Sell |
|
|||||
|
2025
Q1 | $460M | Buy |
|
|||||
|
2024
Q4 | $711M | Hold |
|
|||||
|
2024
Q3 | $993M | Buy |
|
|||||
|
2024
Q2 | $619M | Hold |
|
|||||
|
2024
Q1 | $560M | Buy |
|
|||||
|
2023
Q4 | $496M | Hold |
|
|||||
|
2023
Q3 | $402M | Hold |
|
|||||
|
2023
Q2 | $394M | Buy |
|
|||||
|
2023
Q1 | $273M | Buy |
|
|||||
|
2022
Q4 | $281M | Buy |
|
|||||
|
2022
Q3 | $110M | Hold |
|
|||||
|
2022
Q2 | $99.7M | Hold |
|
|||||
|
2022
Q1 | $111M | Buy |
|
|||||
|
2021
Q4 | $101M | Buy |
|
|||||
|
2021
Q3 | $98.9M | Buy |
|
|||||
|
2021
Q2 | $87M | Hold |
|
|||||
|
2021
Q1 | $76.3M | Buy |
|
|||||
|
2020
Q4 | $98.6M | Sell |
|
|||||
|
2020
Q3 | $261M | Sell |
|
|||||
|
2020
Q2 | $174M | Buy |
|